French Infrastructure Stock News

Safran (ENXTPA:SAF) has quietly added to its strong run this year, with the stock edging higher over the past week and sitting on roughly 43% gains year to date. See our latest analysis for Safran. That latest move takes Safran’s share price to about €306.3, capping a strong year in which the share price return and longer term total shareholder returns suggest momentum is still building rather than fading. If Safran’s run has you rethinking your aerospace exposure, this could be a good moment...

DBV Technologies recently reported that its Phase 3 VITESSE trial of the VIASKIN Peanut patch for peanut‑allergic children aged 4–7 met its primary endpoint with statistically significant efficacy and a favorable safety profile, and the company now plans to submit a Biologics License Application to the US FDA in the first half of 2026. An important angle for investors is that this late-stage success follows earlier regulatory setbacks, suggesting the redesigned patch and trial design may...

In July 2025, Laura Burdese took over as CEO of Bulgari, succeeding long-time leader Jean-Christophe Babin, who remains chairman and head of the Bulgari Hotel business unit. This leadership reshuffle at one of LVMH’s key jewelry and hospitality brands could subtly reshape how the group balances heritage with expansion. We’ll now explore how Burdese’s appointment at Bulgari might influence LVMH’s broader investment narrative, especially around brand diversification and luxury hospitality. The...

Recent reports show that resale premiums for Hermès Birkin and Kelly bags have cooled from very large multiples of original prices to lower levels, even as luxury asset manager LUXUS, backed by Christie’s, launches new handbag investment funds focused on these models. This mix of softer secondary-market pricing and financialization of Hermès icons highlights how the brand now sits at the intersection of consumer demand, collectibles culture, and alternative investments. We’ll now examine how...

If you are wondering whether Atos at around €46 is a turnaround bargain or a value trap, you are not the only one. That is exactly what this breakdown is going to tackle. The stock has swung hard lately, down 15.9% over the last week but still up 6.0% over 30 days, with an eye catching 85.8% gain year to date and a 121.2% rise over the past year after a brutal multi year slide. Those moves come after years of restructuring and strategic shifts that have investors rethinking the long term...

If you are wondering whether BNP Paribas is still good value after a strong run, you are not alone. This article is going to unpack what is really priced into the shares today. The stock has climbed to around €80.24, with returns of 2.0% over the last week, 20.3% over the last month, 35.4% year to date and an impressive 52.8% over the past year. This naturally raises the question of how much upside might be left. Recently, the market has focused on BNP Paribas strategic push in European...

Recent Performance and Context STMicroelectronics (ENXTPA:STMPA) has been drifting in a tight range, with the stock roughly flat over the past week but up about 14% this month, even as its past 3 months remain negative. See our latest analysis for STMicroelectronics. Zooming out, STMicroelectronics has had a choppy ride, with the recent 13.68% 1 month share price return offering a partial rebound against a weaker year to date share price trend and negative multi year total shareholder...

As the European market experiences mixed movements, with indices such as Germany's DAX gaining while others like France's CAC 40 see declines, investors are keeping a close eye on potential policy shifts from the European Central Bank. In this environment of economic resilience and cautious optimism, dividend stocks can offer stability and income, making them an attractive consideration for those looking to navigate these uncertain times.

Pernod Ricard (ENXTPA:RI) has had a rough year in the market, with the share price slipping almost 30% year to date, even as revenues and net income are still inching higher. See our latest analysis for Pernod Ricard. That slump contrasts with a modest 1 week share price return of 1.9%, suggesting bargain hunters are testing the waters even as the 1 year total shareholder return of negative 25.3% shows momentum has clearly faded over a longer stretch. If you are reassessing your portfolio...

Getlink (ENXTPA:GET) has been drifting in a tight range recently, and that kind of quiet tape often hides useful clues. Let us dig into what the latest returns suggest about sentiment and value. See our latest analysis for Getlink. Zooming out, the share price has been broadly range bound this year, yet a positive 1 year total shareholder return of 4.6 percent suggests the market still sees steady, if unspectacular, progress rather than a sharp re rating. If Getlink has you thinking about...

As the European markets navigate mixed performances, with indices like Germany’s DAX gaining slightly and others such as France’s CAC 40 experiencing declines, investors are closely watching policy signals from the European Central Bank. In this context, penny stocks—often representing smaller or newer companies—remain a relevant investment area despite their somewhat outdated label. This article will explore three noteworthy penny stocks in Europe that may offer unique opportunities by...

As European markets navigate mixed signals with some indices like Germany's DAX showing gains while others such as France’s CAC 40 Index face declines, investors are keeping a close eye on economic indicators and central bank policies that could influence small-cap performance. In this environment, identifying promising small-cap stocks requires a keen understanding of how these companies can leverage current market conditions to their advantage, particularly in sectors poised for growth...

As the European market experiences a mix of gains and losses, with Germany's DAX showing positive momentum while France's CAC 40 and the UK's FTSE 100 see slight declines, investors are closely watching the European Central Bank's potential rate hikes amid resilient economic indicators. In this fluctuating environment, dividend stocks can offer a stable income stream, making them an attractive option for those seeking to balance growth with regular returns.

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

If we're looking to avoid a business that is in decline, what are the trends that can warn us ahead of time? More often...

Key Insights Significant control over ERAMET by state or government implies that the general public has more power to...

Key Insights Imerys' estimated fair value is €43.19 based on 2 Stage Free Cash Flow to Equity Imerys' €23.42 share...

Compagnie des Alpes SA ( EPA:CDA ) shareholders would be excited to see that the share price has had a great month...

Sanofi halted development of tolebrutinib in primary progressive multiple sclerosis after the drug missed its Phase 3 primary endpoint. The company signed a licensing deal worth up to $1.04 billion with ADEL for an investigational Alzheimer’s antibody. Sanofi expanded its collaboration with Dren Bio to advance next generation B cell targeted therapies for autoimmune diseases. Regulatory progress includes approvals for new rare disease medicines in China and EMA orphan designation for an...

ABIVAX Société Anonyme (ENXTPA:ABVX) has had a mixed run lately, slipping over the past week but still sitting comfortably above its level from the past 3 months and year to date. See our latest analysis for ABIVAX Société Anonyme. Despite a 15.7% seven day share price pullback, ABIVAX Société Anonyme still boasts a powerful year to date share price return and robust one year total shareholder return, which may suggest that longer term momentum is still very much alive. If ABIVAX has piqued...

The cooling frenzy around Birkin and Kelly resale prices is giving investors a fresh lens on Hermès International Société en commandite par actions (ENXTPA:RMS), as the broader luxury market digests inflation driven pressure and shifting demand. See our latest analysis for Hermès International Société en commandite par actions. Even with chatter about softer Birkin and Kelly premiums, Hermès’ latest share price of €2,144 sits on a modest recent upswing, and the stock’s long term total...

DBV Technologies (ENXTPA:DBV) just cleared a key hurdle, reporting that its Viaskin Peanut patch hit the primary endpoint in the pivotal Phase 3 VITESSE trial, and the stock reacted immediately. See our latest analysis for DBV Technologies. The VITESSE win caps a remarkable run, with DBV Technologies posting a roughly 470% year to date share price return and a 534% one year total shareholder return that signals powerful, event driven momentum rather than a slow grind higher. If this kind of...

Thales (ENXTPA:HO) just rolled out its AI Security Fabric, a platform aimed at shielding Agentic AI and LLM apps from threats like prompt injection and data leakage, and the stock is starting to reflect that shift. See our latest analysis for Thales. That launch lands after a strong run, with the latest share price at €231.2 and a year to date share price return of 68.02 percent. The five year total shareholder return of 241.04 percent shows longer term momentum has been firmly building...

TotalEnergies (ENXTPA:TTE) just locked in a 21 year deal to supply Google’s Malaysian data centers with solar power from its upcoming Citra Energies plant, a long term contract that underlines its shift toward cash flows driven by renewables. See our latest analysis for TotalEnergies. Deals like the Google PPA, plus recent asset sales and upstream portfolio tweaks, are landing against a backdrop where the latest share price of $55.43 sits on modest positive momentum, with a mid single digit...